Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122) [Phase 3]
Phase 3 trial of pembrolizumab in platinum-pretreated recurrent/metastatic nasopharyngeal cancer completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating toripalimab (JS001) in advanced gastric cancer and multiple squamous cell carcinomas including esophagea…
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Individualized Elective Neck Irradiation Based on MRI in NPC Patients [Phase 3]
Phase 3 trial evaluating individualized elective neck irradiation based on MRI in nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating proton radiotherapy with chemotherapy for nasopharyngeal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial evaluating tirelizumab plus surgery versus surgery alone for recurrent nasopharyngeal carcinoma is ongoing with status not s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial comparing ICCRT versus CRT for locally advanced nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial evaluating four cycles of neoadjuvant chemotherapy followed by concurrent chemoradiation in N2-3 nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy [Phase 2]
Phase 2 clinical trial evaluating the impact on xerostomia in nasopharyngeal carcinoma patients treated with or without superficial parotid …
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 1, Phase 2]
Clinical trial update for SHR-1701 combined with famitinib in recurrent/metastatic nasopharyngeal carcinoma (Phase 1/Phase 2) with status cu…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating reduced-dose radiotherapy in low-risk stage III nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial [Phase 2]
A Phase II prospective single-arm study evaluating concurrent chemoradiotherapy with toripalimab for locally recurrent nasopharyngeal carcin…
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial assessing safety and efficacy of PDR001 in recurrent or metastatic nasopharyngeal carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating surufatinib combined with toripalimab in recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing camrelizumab plus stereotactic body radiotherapy versus camrelizumab alone in oligometastatic nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis [Phase 2]
Phase 2 clinical trial update for Tegio consolidation therapy in nasopharyngeal carcinoma patients at high risk of metastasis.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating sintilimab with multimodal radiotherapy in recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC [Phase 2, Phase 3]
An open-label Phase II/III randomized trial comparing PFLL versus GP combined with JS001 as first-line therapy for metastatic nasopharyngeal…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating toripalimab plus surgery versus surgery alone in resectable recurrent nasopharyngeal carcinoma is currently recruit…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma [Phase 2]
Phase II trial of camrelizumab in patients with nasopharyngeal carcinoma without distant metastasis is being conducted; current status is un…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating paclitaxel albumin-bound with cisplatin, PD-1 inhibitors, and IMRT in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating paclitaxel albumin-bound with radiotherapy for early-stage nasopharyngeal carcinoma is ongoing but results are not …
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating S-1 combined with IMRT concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Endostar for Locally Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update for Endostar in locally recurrent nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT [Phase 3]
Phase 3 trial evaluating the role of concurrent chemotherapy for lower risk locally advanced nasopharyngeal carcinoma in the IMRT era.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update evaluating nimotuzumab in combination with VMAT for elderly patients with nasopharyngeal carcinoma.